Invitrogen™ Human BCAR3 Synthetic Peptide
BCAR3 Synthetic Peptide, PEP-1467, from Invitrogen.
- Gene ID (Enter)
- 8412
- Species
- Human
- Purification method
- Purified
- Accession number
- O75815
- Common name
- Human BCAR3
- Brand
- Invitrogen
BCAR3 Synthetic Peptide, PEP-1467, from Invitrogen.
BCAR3 Synthetic Peptide, PEP-1467, from Invitrogen.
Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15225379 |
| Specifications | |
| Gene ID (Enter) | 8412 |
| Species | Human |
| Purification method | Purified |
| Accession number | O75815 |
| Common name | Human BCAR3 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | BCAR3 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1467 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |